Metformin, but not pioglitazone, decreases postchallenge plasma ghrelin levels in type 2 diabetic patients: a possible role in weight stability?
https://doi.org/10.14341/2071-8713-5321
For citations:
Metformin, but not pioglitazone, decreases postchallenge plasma ghrelin levels in type 2 diabetic patients: a possible role in weight stability? Obesity and metabolism. 2009;6(2):50-51. (In Russ.) https://doi.org/10.14341/2071-8713-5321

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).